Doctor of Osteopathy Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Hunter Aronson

Orthopaedic Surgery Greeley, CO Doctor of Osteopathy

NPI 1174186969 CMS profile 11423499

5890 W 13Th St Ste 101, Greeley, CO 80634

Open in the dashboard

General payments

$9,617

92 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Hunter Aronson of Greeley, CO is reported in the CMS Open Payments database as having received $9,617 across 92 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $943 15
2024 General $3,937 30
2023 General $2,847 27
2022 General $1,890 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hunter Aronson
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Hunter Aronson were reported at $943. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Hunter Aronson Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $0 $520 $117–$2,495 $132
2022 $1,890 $598 $128–$2,731 $149
2023 $2,847 $461 $128–$2,264 $160
2024 $3,937 $497 $134–$2,475 $164
2025 $943 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Stryker Corporation $6,941 67 payments
  2. Medwest Associates $1,436 4 payments
  3. DePuy Synthes Sales Inc. $677 9 payments
  4. Zimmer Biomet Holdings, Inc. $245 5 payments
  5. Bioventus LLC $162 2 payments
  6. Medical Device Business Services, Inc. $110 3 payments
  7. Sanofi-Aventis U.S. LLC $29 1 payment
  8. Ferring Pharmaceuticals Inc. $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $4,872 79 payments
  2. Travel and Lodging $3,546 12 payments
  3. Education $1,200 1 payment
Products named General payments · program years 2022–2025
  1. MAKO $3,765 27 payments
  2. TRIATHLON $930 11 payments
  3. GMRS $900 1 payment
  4. ACTIS $392 4 payments
  5. INSIGNIA $344 6 payments
  6. NA $272 4 payments
  7. T2 $265 3 payments
  8. ACCOLADE $227 5 payments
  9. PRIME SERIES $191 5 payments
  10. GAMMA $185 2 payments
  11. Other $1,148 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 23 billing codes

Paid by Medicare

$27,318

Medicare's payments for the services billed

Medicare patients

113

Average age 77

Services billed

241

79 women, 34 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Ischemic heart disease 28%
Atrial fibrillation 21%
Chronic kidney disease 21%
Osteoporosis 21%
Depression 20%
COPD 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

92 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record